Is xyphosinc.com Safe? Security Analysis for Xyphos Inc
https://xyphosinc.comCheck if xyphosinc.com is a scam or legitimate. Free security scan and reviews.
Below Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for xyphosinc.com
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Xyphos Biosciences, Inc. is a small biotechnology company specializing in the development of flexible and adaptable immune cell therapies aimed at revolutionizing cancer care. The company operates as a subsidiary of Astellas Pharma Inc., leveraging its parent company's resources and market presence. The website clearly targets cancer patients, healthcare professionals, investors, and potential employees, showcasing innovation in next-generation cancer immunotherapy. The business model focuses on research and development of controllable immune therapies with a strong emphasis on safety and efficacy. Technically, the website is built on WordPress and employs modern JavaScript libraries such as jQuery, Slick Carousel, and FancyApps UI. Hosting is provided by GoDaddy, and the site uses HTTPS with a good SSL configuration. Performance is moderate with good mobile optimization and basic accessibility features. SEO is well addressed with proper meta tags and structured data. However, there is room for improvement in accessibility and performance optimization. From a security perspective, the site benefits from HTTPS and lacks exposed sensitive data. However, it does not implement DNSSEC, nor does it use common security headers like Content-Security-Policy or HSTS. There are no published security policies or incident response contacts, and privacy compliance is weak due to the absence of privacy and cookie policies. Google Analytics is used for tracking, indicating moderate user tracking without clear privacy disclosures. Overall, the website presents a professional and credible business front with strong ties to a reputable parent company. The main risks lie in privacy compliance and security hardening. Strategic recommendations include implementing comprehensive privacy and cookie policies, enabling DNSSEC, adding security headers, and publishing security and incident response policies to enhance trust and compliance.
Detected Technologies
11 urgent findings need attention
11 high
- + 3 more findings in the full report below
Keep xyphosinc.com under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
5 findings
60/100
GDPR Compliance
4 findings
35/100
NIS2 Compliance
8 findings
17/100
Email Security
4 findings
70/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Xyphos Biosciences positions itself as an innovator in the cancer immunotherapy sector, focusing on flexible immune cell therapies. Its affiliation with Astellas Pharma provides competitive advantages including financial backing and market access. The business model is research-driven with potential revenue streams from partnerships, licensing, and eventual product commercialization. The target customers include healthcare providers and patients seeking advanced cancer treatments. Growth indicators include active recruitment and pipeline visibility through parent company links. The partnership ecosystem is strong, leveraging Astellas' global presence. Operationally, the company maintains a focused digital presence with professional branding and clear messaging aligned with its mission.
Extracted Contact Information
Marketing Intelligence Data
Physical Addresses (1)
Security Posture Analysis
Comprehensive Security Assessment
The current security maturity level is moderate. HTTPS is enforced, and no sensitive data leaks were detected. However, the absence of DNSSEC and security headers exposes the site to potential DNS spoofing and clickjacking risks. The lack of published security policies and incident response contacts indicates limited transparency and preparedness. Compliance gaps exist in privacy and cookie policy disclosures, which may affect GDPR and other regulatory adherence. The use of third-party scripts like Google Analytics introduces tracking without clear user consent mechanisms. Overall, the security culture appears basic, with opportunities to enhance governance and technical controls.
Strategic Recommendations
Priority Actions for Security Improvement
Implement a comprehensive privacy policy and cookie consent mechanism to improve GDPR compliance.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Xyphos Inc
At Xyphos, we’re working to deliver flexible and adaptable cancer therapies with the potential to revolutionize cancer care.
good
consistent
Technical Stack
moderate
good
basic
good
Security Assessment
- HTTPS enabled
- No exposed sensitive data in HTML
- Use of security-related meta tags (robots)
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is professionally designed and content-rich focused on cancer immunotherapy
Get this report delivered to your inbox
Receive a summary of the xyphosinc.com security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Weak Strict-Transport-Security configuration
LOWCurrent value: "max-age=300, max-age=31536000; includeSubDomains"
Missing X-Frame-Options header
HIGHPrevents clickjacking attacks
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Privacy Policy found
HIGHGDPR requires a clear and accessible privacy policy
No Cookie Policy found
HIGHGDPR requires clear information about cookie usage
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
Third-party services without privacy policy
HIGHDetected services: Google Analytics, LinkedIn, Google APIs
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Need this report as a PDF?
Download the complete xyphosinc.com security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No DKIM record found
MEDIUMDKIM adds cryptographic signatures to emails
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
SPF Details
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 54 days
Weak SSL Key Length
HIGHSSL certificate uses 256-bit key, which is considered weak
Mixed Content Detected
MEDIUM1 resources loaded over insecure HTTP
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
No DMARC Record
MEDIUMDMARC policy not configured
DNS Records
DNSSEC Status
DNS Performance
SPF Analysis
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does xyphosinc.com compare?
See how xyphosinc.com stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the xyphosinc.com report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the xyphosinc.com report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about xyphosinc.com
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published